RNAZ stock

TransCode Therapeutics Inc [NASDAQ: RNAZ] traded at a high on Friday, posting a 2.55 gain after which it closed the day’ session at $0.68. The company report on January 31, 2024 at 4:05 PM that Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement

TransCode Therapeutics Inc [NASDAQ: RNAZ] traded at a low on Thursday, posting a -1.29 loss after which it closed the day’ session at $0.68. The company report on January 31, 2024 at 4:05 PM that Nasdaq Determines TransCode Therapeutics Compliance with Minimum Stockholders’ Equity Requirement